News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Janus Portfolio Manager Sees More Biotech Gains On Trump



11/18/2016 7:07:44 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Biotech stocks still have room to rise after the election of Donald Trump as U.S. president, which removed threats of drug price controls that had pushed shares to historically cheap levels this year, a top portfolio manager for Janus said on Wednesday.

The Nasdaq Biotechnology index .NBI has climbed 11 percent since the election, but still remains down 14 percent for 2016.

Given the deregulation of healthcare signaled by Donald Trump, who was elected last week in a surprise victory, that is not enough, according to Janus Global Life Sciences co-portfolio manager Ethan Lovell.

Read at Reuters


comments powered by Disqus
Reuters
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES